Skip to content

CollPlant Biotechnologies Ltd.

CLGN

CIK 0001631487

← back to feed
Revenue (TTM)
$11.19M
+360.4% YoY FY Dec 2025
Net Income (TTM)
−$5.77M
+30.8% YoY FY Dec 2025
EPS Diluted (TTM)
−$0.57
+35.2% YoY FY Dec 2025
Gross Margin
85.5%
FY Dec 2025
Operating Margin
-53.4%
FY Dec 2025
Net Margin
-51.6%
FY Dec 2025
Free Cash Flow (TTM)
−$9.45M
FY Dec 2025
Cash
$5.59M
FY Dec 2025
Total Debt
$351K
FY Dec 2025
Shares Outstanding
12.8M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings